Daniel Apel

Daniel Apel is a seasoned financial executive currently serving as the Chief Financial Officer at Arrowhead Pharmaceuticals since April 2025. Previously, Daniel held the position of Global Head of Financial Planning & Analysis at Walgreens Boots Alliance from January 2019 to July 2024. Prior to that role, Daniel was the Chief Financial Officer at Bayer U.S. from January 2016 to January 2019 and served as Senior Vice President at Bayer HealthCare, managing multiple executive responsibilities from January 2012 to January 2016. Additionally, Daniel was Senior Vice President, Head of CAO at Bayer Healthcare Pharmaceuticals, Inc. from January 2009 to January 2012. Daniel holds a Master of Business Administration from the University of California, Berkeley, Haas School of Business and a Bachelor of Arts in Economics with a Mathematics minor from the University of Pennsylvania.